The quackery of -traditional- psychiatry & psychology in America.
Drugs, drugs, and more drugs…….
“I would say at least half the folks who are being treated with antidepressants aren’t benefiting from the active pharmacological effects of the drugs themselves but from a placebo effect, If people knew more, I think they would be a little less likely to go down the medication path than the psychosocial treatment path.”
Steven Hollon….Inappropriate prescribing….American Psychological Association, Volume 43 #6….2012…page 36
“Practice is not reflecting the research. Ninety to 95% of programs have no research base. The gap between what is known and what is being provided in routine care is huge.”
Kimberly Hogwood [New York Office Of Mental Health] Associated Press, The Daily Texan, April 11, 2002
“The U.S. mental health system is in crisis….according to a federal report.”
“The fundamental problem: emphasizing medicating people over fostering ways to help them lead productive lives.”
Associated Press, The Daily Texan [September 17, 2002]
“The difference between the effect of a placebo and the effect of an anti-depressant is minimal for most people……People get better when they take the drug, but its not the chemical ingredients in the drug that are making them better, its largely the placebo effect.”
Irving Kirsch [Associate Director Placebo Studies, Harvard Medical School]
“……the benefits that US health care currently deliver may not outweigh the aggregate health harm it imparts.”
Journal Of The American Medical Association…Volume 302 #1..July 1, 2009…page 89 – 91
“Most drugs are only effective for a small percentage of people who take them.”
[Michael Leavitt….U.S. Secretary of Health & Human Services 2005 – 2009]

TheETG competent self-care
TheETG repair of brain cell overwork, overwhelm, “mental illness” —–
TheETG human psychology —–
ETG info: addiction —–

Cognitive Behavior Therapy [CBT] and Cognitive Enhancement Therapy tend to be the among the only treatments for depression, schizophrenia, and various forms of “mental illness” that address the underlying issues of brain cell loss. Arguably “mental illness” is due to brain cell loss. The drug approach focuses on neurotransmitters, ignoring the loss of brain cells that produce the neurotransmitters.
Cognitive Behavior Therapy
National Association Of Cognitive Behavioral Therapy [CBT]
—– find a CBT practitioner in your area
—– Online counseling in Cognitive Behavioral Therapy
“The evidence base for cognitive behavioral therapy (CBT) for depression is discussed…….identifies the need to deliver evidence-based psychosocial interventions and identifies cognitive behavioral therapy as having the strongest research base for effectiveness….”
G.Whitefield, et al
The evidence base for cognitive–behavioural therapy in depression: delivery in busy clinical settings
Advances in Psychiatric Treatment….Volume 9….2003… 21 – 30
“Studies have shown that cognitive therapy is as efficacious as antidepressant medications at treating depression, and it seems to reduce the risk of relapse even after its discontinuation.”
Cognitive therapy vs. medications for depression: Treatment outcomes and neural mechanisms
Nature Reviews Neuroscience…..Volume 9 #10….October 2008….page 788
“Many studies have confirmed the efficacy of cognitive behavioral therapy (CBT) as a treatment for depression.”
“Findings supported the research hypothesis that the more individuals improved their problem-solving appraisal, the more their depression decreased.”
“Additionally, it was discovered that the poorer individuals’ problem-solving appraisal before the cognitive behavioral therapy, the more improvement they had on depression and problem solving appraisal after the cognitive behavioral therapy.”
“In sum, findings suggested that problem-solving appraisal might play an important part in cognitive behavioral therapy for depression reduction…..”
Szu.Y.Chen et al
The Effect of Cognitive Behavioral Therapy (CBT) on Depression: The Role of Problem-Solving Appraisal
Research on Social Work Practice……Volume 16 #5……September 2006… 500 – 510
“Cognitive rehabilitation has shown efficacy in improving cognition in patients with schizophrenia….”
“A 2-year trial with annual structural magnetic resonance imaging and cognitive assessments.”
“Patients who received cognitive enhancement therapy demonstrated significantly greater preservation of gray matter volume over 2 years in the left hippocampus, parahippocampal gyrus, and fusiform gyrus, and significantly greater gray matter increases in the left amygdala….”
“Less gray matter loss in the left parahippocampal and fusiform gyrus and greater gray matter increases in the left amygdala were significantly related to improved cognition and mediated the beneficial cognitive effects of cognitive enhancement therapy.”
S.M.Eack, et al
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial
Archives Of General Psychiatry…..Volume 67 #7……May 2010… 674 – 682
“Depression and anxiety are highly prevalent in patients with cardiovascular disease (CVD) and influence their mental well-being and cardiovascular disease prognosis. The primary objective was to assess the effectiveness of cognitive behavioral therapy (CBT) for depression and anxiety in patients with cardiovascular disease. Secondary objectives were to assess the impact of cognitive behavioral therapy on cardiovascular mortality, cardiovascular events, patient satisfaction, and quality of life.”
“12 randomized controlled trials were included. At follow-up, depression and anxiety scores were significantly lower in cognitive behavioral therapy patients compared with controls. Change in mental health quality of life was also significantly greater for cognitive behavioral therapy patients, compared with controls.”
“Among the study reports included in this meta-analysis, data specific to cardiovascular mortality were not reported.”
“Cognitive behavioral therapy….should be considered in standard clinical care.”
.J.Reavell, et al
Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis
Psychosomatic Medicine — Volume 80 #8 — October 2018 — page 742